Keyword: Mayo Clinic

The investment sets the Kite Pharma-partnered firm up to refine software to orchestrate the many steps involved in the production of cell therapies.

The IPO comes as the Flagship startup prepares to test its lead inflammatory disease and anticancer microbial strains in humans.

The new funding will propel Unity Biotechnologies' osteoarthritis asset into its first clinical trial.

Pairing the algorithm with AliveCor’s smartphone and Apple Watch-based ECGs could enable the remote, noninvasive monitoring of potassium levels.

Helix plans to expand its DNA test marketplace this year to offer over 50 products, including launches from companies like Mayo Clinic.

French scientists discovered that an X chromosome-linked abundance of a toll-like receptor could be the root cause of lupus.

Evelo Biosciences has just forged closer ties with a heavyweight academic partner for its monoclonal microbials R&D, which envisages using bacteria to fight disease.

Personal genomics player Helix has launched an online marketplace for “DNA-powered products,” including Sema4's saliva-based carrier test from Sema4.

Check out the rest of Thursday's news of note.

Mayo Clinic and AliveCor are developing a low-cost, portable screening tool for long QT, which can cause sudden cardiac death.